Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2026
Single-anastomosis duodenoileal bypass versus one-anastomosis gastric bypass: 1-year results of the OASIS randomized trial.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sanchez-Cordero Sergi, Lopez-Gonzalez Ruth, Garcia Paula, Castellvi Jordi, Pujol-Gebelli Jordi
Аннотация
BACKGROUND: Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) and one-anastomosis gastric bypass (OAGB) are increasingly used bariatric procedures, but high-quality comparative evidence remains limited.
OBJECTIVES: To compare 1-year efficacy and safety outcomes of SADI-S and OAGB as primary bariatric procedures in patients with severe obesity.
SETTING: Secondary care bariatric surgery center.
METHODS: This was a single-center, prospective, randomized, single-blind controlled trial. Ninety-nine patients aged 18-65 years with body mass index (BMI) 45-50 kg/m2 were enrolled between 2023 and 2024; 90 underwent surgery (43 SADI-S; 47 OAGB). Patients were randomly assigned (1:1) using a computer-generated sequence. The primary outcome was excess weight loss (EWL) at 1 year. The secondary outcomes included total weight loss (TWL), BMI, late complications (>30 days), comorbidity resolution, nutritional deficiencies, and quality of life.
RESULTS: At 1 year, no significant differences were observed between groups in EWL (84.34% vs 79.61%; P = .209), TWL (35.85% vs 33.02%; P = .075), or BMI (27.93 vs 28.92 kg/m2; P = .168). Comorbidity resolution rates were comparable. Nutritional deficiencies were infrequent (7.3% vs 4.3%; P = .878), with all cases related to iron deficiency. Late complications were significantly more frequent after OAGB (35.4% vs 7.1%; P = .0003), mainly related to bile reflux and managed conservatively or endoscopically. SADI-S was associated with fewer complications but included two cases requiring surgical reintervention. One death occurred in the SADI-S group and was not directly attributable to the procedure. Quality of life improved similarly in both groups.
CONCLUSIONS: SADI-S and OAGB achieved comparable weight loss and metabolic outcomes at 1 year in patients with BMI 45-50 kg/m2 but showed distinct complication profiles. OAGB was associated with a higher rate of bile reflux-related events, whereas SADI-S had fewer but more severe complications. These findings support an individualized approach to procedure selection. Longer-term follow-up is required.
OBJECTIVES: To compare 1-year efficacy and safety outcomes of SADI-S and OAGB as primary bariatric procedures in patients with severe obesity.
SETTING: Secondary care bariatric surgery center.
METHODS: This was a single-center, prospective, randomized, single-blind controlled trial. Ninety-nine patients aged 18-65 years with body mass index (BMI) 45-50 kg/m2 were enrolled between 2023 and 2024; 90 underwent surgery (43 SADI-S; 47 OAGB). Patients were randomly assigned (1:1) using a computer-generated sequence. The primary outcome was excess weight loss (EWL) at 1 year. The secondary outcomes included total weight loss (TWL), BMI, late complications (>30 days), comorbidity resolution, nutritional deficiencies, and quality of life.
RESULTS: At 1 year, no significant differences were observed between groups in EWL (84.34% vs 79.61%; P = .209), TWL (35.85% vs 33.02%; P = .075), or BMI (27.93 vs 28.92 kg/m2; P = .168). Comorbidity resolution rates were comparable. Nutritional deficiencies were infrequent (7.3% vs 4.3%; P = .878), with all cases related to iron deficiency. Late complications were significantly more frequent after OAGB (35.4% vs 7.1%; P = .0003), mainly related to bile reflux and managed conservatively or endoscopically. SADI-S was associated with fewer complications but included two cases requiring surgical reintervention. One death occurred in the SADI-S group and was not directly attributable to the procedure. Quality of life improved similarly in both groups.
CONCLUSIONS: SADI-S and OAGB achieved comparable weight loss and metabolic outcomes at 1 year in patients with BMI 45-50 kg/m2 but showed distinct complication profiles. OAGB was associated with a higher rate of bile reflux-related events, whereas SADI-S had fewer but more severe complications. These findings support an individualized approach to procedure selection. Longer-term follow-up is required.